130 related articles for article (PubMed ID: 8613433)
1. Distribution of transforming growth factor-beta and its receptors in gastric carcinoma tissue.
Kai T; Taketazu F; Kawakami M; Shimanuki K; Yamada S; Miyazono K; Kato M; Miyata M
Jpn J Cancer Res; 1996 Mar; 87(3):296-304. PubMed ID: 8613433
[TBL] [Abstract][Full Text] [Related]
2. The progression of invasiveness regarding the role of transforming growth factor beta receptor type II in gastric cancer.
Tateishi M; Kusaba I; Masuda H; Tanaka T; Matsumata T; Sugimachi K
Eur J Surg Oncol; 2000 Jun; 26(4):377-80. PubMed ID: 10873359
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of major TGF-beta isoforms and their receptors in laryngeal carcinomas.
Hagedorn H; Elbertzhagen A; Ruoss I; Sauer U; Nerlich AG
Virchows Arch; 2001 Oct; 439(4):531-9. PubMed ID: 11710640
[TBL] [Abstract][Full Text] [Related]
4. Role of TGF-beta 1 and TGF-beta type II receptor in gastric cancer.
Park D; Son HJ; Song SY; Choe WH; Lim YJ; Park SJ; Kim JJ; Kim YH; Rhee PL; Paik SW; Rhee JC; Choi KW
Korean J Intern Med; 2002 Sep; 17(3):160-6. PubMed ID: 12353499
[TBL] [Abstract][Full Text] [Related]
5. Roles of the transforming growth factor beta 1 and its type I and II receptors in the development of a pulmonary adenocarcinoma: results of an immunohistochemical study.
Takanami I; Tanaka F; Hashizume T; Kodaira S
J Surg Oncol; 1997 Apr; 64(4):262-7. PubMed ID: 9142180
[TBL] [Abstract][Full Text] [Related]
6. Differential localization of transforming growth factor-beta isoforms in human gastric mucosa and overexpression in gastric carcinoma.
Naef M; Ishiwata T; Friess H; Büchler MW; Gold LI; Korc M
Int J Cancer; 1997 Apr; 71(2):131-7. PubMed ID: 9139831
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical studies of transforming growth factor-beta and its receptors in the gastric mucosa of patients with refractory gastric ulcer.
Shih SC; Chien CL; Tseng KW; Lin SC; Kao CR
J Formos Med Assoc; 1999 Sep; 98(9):613-20. PubMed ID: 10560237
[TBL] [Abstract][Full Text] [Related]
8. Immunoreactivity of monoclonal antibody BW835 represents a marker of progression and prognosis in early gastric cancer.
Baldus SE; Zirbes TK; Glossmann J; Fromm S; Hanisch FG; Mönig SP; Schröder W; Schneider PM; Flucke U; Karsten U; Thiele J; Hölscher AH; Dienes HP
Oncology; 2001; 61(2):147-55. PubMed ID: 11528254
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
11. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB
Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
[TBL] [Abstract][Full Text] [Related]
12. Cellular distribution of transforming growth factor betas 1, 2, and 3 and their types I and II receptors during postnatal development and spermatogenesis in the boar testis.
Caussanel V; Tabone E; Hendrick JC; Dacheux F; Benahmed M
Biol Reprod; 1997 Feb; 56(2):357-67. PubMed ID: 9116134
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS
J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical study of collagen in gastric cancer tissue].
Kondou S; Kanayama K; Morise K
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Apr; 18(2):168-77. PubMed ID: 7553051
[TBL] [Abstract][Full Text] [Related]
15. Reduced levels of transforming growth factor-beta type I receptor in human gastric carcinomas.
Ito M; Yasui W; Nakayama H; Yokozaki H; Ito H; Tahara E
Jpn J Cancer Res; 1992 Jan; 83(1):86-92. PubMed ID: 1312080
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma.
Yamada N; Kato M; Yamashita H; Nistér M; Miyazono K; Heldin CH; Funa K
Int J Cancer; 1995 Aug; 62(4):386-92. PubMed ID: 7635563
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: receptor and postreceptor signaling.
Ito M; Yasui W; Kyo E; Yokozaki H; Nakayama H; Ito H; Tahara E
Cancer Res; 1992 Jan; 52(2):295-300. PubMed ID: 1309437
[TBL] [Abstract][Full Text] [Related]
18. Expression of Cbl linking with the epidermal growth factor receptor system is associated with tumor progression and poor prognosis of human gastric carcinoma.
Ito R; Nakayama H; Yoshida K; Matsumura S; Oda N; Yasui W
Virchows Arch; 2004 Apr; 444(4):324-31. PubMed ID: 14991403
[TBL] [Abstract][Full Text] [Related]
19. Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression.
Biasi F; Tessitore L; Zanetti D; Cutrin JC; Zingaro B; Chiarpotto E; Zarkovic N; Serviddio G; Poli G
Gut; 2002 Mar; 50(3):361-7. PubMed ID: 11839715
[TBL] [Abstract][Full Text] [Related]
20. Localization of transforming growth factor-beta1 and type II receptor in developing normal human prostate and carcinoma tissues.
Gerdes MJ; Larsen M; McBride L; Dang TD; Lu B; Rowley DR
J Histochem Cytochem; 1998 Mar; 46(3):379-88. PubMed ID: 9487120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
